# VFinal Scientific Strengthening Addendum V0.1

## Document Status

| Field | Value |
|---|---|
| Document type | Governance strengthening addendum |
| Version | V0.1 |
| Project | OpenEMR IM Core |
| Stage | Documentation-stage governance |
| Scope | Documentation-only |
| Runtime status | Pre-runtime |
| Clinical-use status | Not authorized |
| PHI status | No PHI |
| Real patient data | Not permitted |
| AI implementation | Not permitted |

This document is a documentation-stage governance addendum for the OpenEMR IM Core project.

It does not implement runtime behavior, artificial intelligence, clinical decision support, API/FHIR integration, SQL/database changes, OpenEMR core behavior changes, clinical-use authorization, production readiness, clinical validation, regulatory compliance, or cybersecurity certification.

---

## 1. Purpose

This addendum strengthens the adopted governance execution system:

**OpenEMR IM Core — Evidence-Gated, Risk-Based, Traceability-Driven Clinical Software Governance Execution System VFinal**

The purpose is to improve alignment with:

- medical software lifecycle governance
- risk-based review
- source-of-truth discipline
- traceability
- privacy protection
- evidence-based claims control
- human-owned execution decisions
- future standards-mapping discipline

This addendum does not replace the VFinal governance execution system.

It extends and clarifies it.

---

## 2. Relationship to the VFinal System

The VFinal system remains the governing execution framework for the project.

This addendum is subordinate to the VFinal system and must be interpreted as a strengthening layer.

If any future interpretation appears to conflict with the core safety boundaries of the VFinal system, the stricter safety interpretation applies.

The governing short form remains:

Verify → Classify Risk → Check Source of Truth → Control Claims → Execute Narrow PR → Verify → Re-measure → Revert if Safety Gate Breaks

---

## 3. Non-Negotiable Project Boundaries

The following boundaries apply to this addendum and to all work governed by it.

The project remains:

- documentation-first
- governance-first
- human-supervised
- pre-runtime
- pre-implementation
- pre-clinical-use
- no PHI
- no real patient data
- no secrets
- no credentials
- no production logs
- no database dumps
- no autonomous diagnosis
- no autonomous treatment
- no autonomous prescribing
- no autonomous triage
- no AI implementation
- no prompt execution
- no model integration
- no API/FHIR implementation
- no SQL/database migration
- no OpenEMR core behavior change
- no clinical-use authorization
- no production-readiness claim
- no clinical-validation claim
- no regulatory-compliance claim
- no cybersecurity-certification claim

Any step that violates these boundaries is a **NO-GO** unless a future formally authorized governance gate explicitly permits it with evidence, human approval, and documented safety controls.

---

## 4. Risk Mapping Clarification

The project uses internal risk categories to control documentation-stage execution.

These categories are:

- Low Risk
- Medium Risk
- High Risk
- Critical Risk

These are project governance categories.

They are not formal IEC 62304 software safety classes.

If the project later enters an authorized software development, runtime, validation, or clinical-use preparation phase, a separate formal software safety classification and risk-management process must be created, reviewed, and approved.

---

## 5. Internal Risk Categories

### 5.1 Low Risk

Low Risk changes are documentation-only, administrative, formatting, index-only, typo, or verification-only changes.

They must have no impact on:

- clinical safety
- privacy
- runtime behavior
- AI behavior
- API/FHIR integration
- SQL/database structure
- OpenEMR core behavior
- regulatory claims
- validation claims
- production-readiness claims
- cybersecurity-certification claims

Examples:

- typo correction
- Markdown formatting correction
- index entry for an already verified document
- grep-based verification
- changed-files verification
- whitespace cleanup
- claim wording correction without new governance scope

Default decision:

GO after verification

External specialized review is usually not required.

---

### 5.2 Medium Risk

Medium Risk changes affect documentation structure or governance organization while remaining documentation-only and pre-runtime.

Examples:

- workflow planning documentation
- source-of-truth cleanup
- documentation overlap reduction
- roadmap sequencing clarification
- governance structure clarification
- Documentation Index restructuring
- Golden Catalog alignment indexing
- limited platform planning clarification

Default decision:

GO or CONDITIONAL GO after source-of-truth and boundary checks

External specialized review is case-by-case.

---

### 5.3 High Risk

High Risk changes involve sensitive planning or governance areas.

Examples:

- clinical safety
- AI/CDS governance
- privacy/security
- validation planning
- release readiness
- regulatory wording
- workflow architecture
- platform strategy
- sandbox transition planning
- future runtime implications
- clinical intelligence documentation
- human-in-the-loop review design
- audit and explainability planning

Default decision:

CONDITIONAL GO, SPLIT, or DEFER after specialized review

External specialized review is required unless the project owner explicitly documents why it is not needed.

---

### 5.4 Critical Risk

Critical Risk includes any step that could breach project safety boundaries.

Examples:

- PHI
- real patient data
- runtime AI
- prompt execution
- model integration
- API/FHIR implementation
- SQL/database migration
- OpenEMR core behavior change
- autonomous clinical decision-making
- clinical-use authorization
- production-readiness claim
- clinical-validation claim
- regulatory-compliance claim
- cybersecurity-certification claim

Default decision:

NO-GO

A future authorized governance gate is required before reconsideration.

---

## 6. Future Formal Standards Mapping Gate

A future-only gate is added:

Formal Standards Mapping Gate

### 6.1 Purpose

Before any transition from documentation-stage governance into runtime planning, implementation, testing, validation, or clinical-use preparation, the project must create a dedicated standards-mapping artifact.

This artifact should map project governance controls to applicable medical software and healthcare software governance references.

Potential references may include:

- IEC 62304 software lifecycle process
- ISO 14971 risk management principles
- ISO 13485 quality management system principles
- IEC 82304-1 health software product safety
- applicable privacy/security requirements
- applicable clinical safety requirements
- applicable human-supervision requirements

### 6.2 Boundary

This standards mapping is future planning only.

It must not claim:

- compliance
- certification
- approval
- validation
- regulatory readiness
- cybersecurity certification
- clinical-use readiness
- production readiness

unless formally evidenced and approved in a later authorized stage.

---

## 7. Strengthened Evidence Gate

Every non-mechanical PR must identify the evidence supporting the change.

The Evidence Gate must answer:

1. What evidence supports the change?
2. Where is the evidence located?
3. Is the evidence internal repository evidence?
4. Is the evidence external standard or guidance evidence?
5. Is the evidence expert review evidence?
6. Is the evidence current enough for the decision?
7. Does the evidence support only documentation-stage planning?
8. Does the evidence imply runtime, clinical, validation, or regulatory claims?
9. What would invalidate the evidence?

### 7.1 Evidence Decision Rules

No evidence → no non-mechanical execution.
Weak evidence → CONDITIONAL GO or DEFER.
Conflicting evidence → SPLIT, DEFER, or NO-GO.
Stale evidence → re-assess before execution.
Runtime-implying evidence → boundary review required.
Clinical-use-implying evidence → NO-GO unless future gate authorized.

### 7.2 Evidence Types

Acceptable evidence may include:

- verified file path
- verified PR result
- verified project-state tracker entry
- repository audit result
- Documentation Index measurement
- grep or script-based verification result
- approved roadmap item
- specialized reviewer output
- human reviewer request
- relevant external standard or guidance reference

Evidence must be specific enough to support the proposed action.

---

## 8. Traceability Minimum Rule

Every non-mechanical PR must be traceable to at least one of the following:

- existing source-of-truth document
- Documentation Index gap
- explicit project-state tracker gap
- approved roadmap item
- approved governance gap
- verified audit finding
- specialized review recommendation
- human reviewer request

The PR body must clearly state:

- why the change is needed
- which document or governance gap it addresses
- which source-of-truth document it updates or references
- why a new document is justified, if applicable
- why updating an existing document is insufficient, if applicable
- what verification supports the change

No non-mechanical PR should exist without a traceable reason.

---

## 9. Source-of-Truth Control

Before creating or modifying governance documentation, the project must identify the applicable source of truth.

The review must ask:

- Does a similar document already exist?
- Is this topic already governed elsewhere?
- Is there a current active document?
- Is there an older historical document?
- Is the better action to update an existing file?
- Is the better action index-only?
- Is the better action a cross-reference?
- Is the better action glossary clarification?
- Would a new document create overlap?
- Would a new document create ambiguity?
- Does the proposed change add real governance value?

### 9.1 Source-of-Truth Decision Rules

Update existing document when possible.
Create a new document only for a distinct governance function.
Use cross-reference when overlap is intentional.
Use index-only when the document already exists and only visibility is missing.
Reject duplicate documents that create ambiguity.
Split mixed-scope changes.
Defer changes that are correct but premature.

---

## 10. No-Duplicate-Document Rule

Before creating any new document in the following areas, a source-of-truth check is mandatory:

- governance
- clinical safety
- AI/CDS
- validation
- workflow
- roadmap
- regulatory
- privacy
- security
- platform planning
- release readiness
- clinical intelligence
- audit and explainability

A new document is justified only if:

- it has a distinct governance function
- it does not duplicate an active document
- it does not weaken source-of-truth clarity
- it does not create conflicting terminology
- it can be indexed clearly
- it can be reviewed as one narrow PR

If these criteria are not met, the preferred action is to update an existing document or create a cross-reference.

---

## 11. Strengthened Claim-Control Gate

The project must avoid claims that imply implementation, validation, regulatory status, production readiness, cybersecurity certification, or clinical authorization.

### 11.1 Prohibited Claims Without Formal Evidence

Do not claim:

- implemented
- active
- live
- operational
- validated
- clinically validated
- approved
- certified
- regulatory compliant
- cybersecurity certified
- production ready
- clinically safe
- ready for patient care
- ready for PHI
- ready for real patient data
- AI-enabled
- CDS-enabled
- FHIR-ready
- API-ready
- database-ready
- autonomous
- diagnostic
- treatment-recommending
- prescribing
- triage-capable

### 11.2 Preferred Safe Wording

Use safer wording such as:

- documentation-stage
- planning-only
- governance-stage
- pre-runtime
- pre-implementation
- human-supervised
- no PHI
- no real patient data
- no clinical-use authorization
- no AI implementation
- no prompt execution
- no model integration
- no API/FHIR implementation
- no SQL/database migration
- no OpenEMR core behavior change
- not production-ready
- not clinically validated
- not regulatory approved
- not cybersecurity certified

### 11.3 Claim-Control Rule

If a document requires stronger wording, the PR must provide explicit evidence and project-owner approval.

If evidence is absent, the claim must be weakened or removed.

---

## 12. Human Ownership Rule

Specialized GPT review may support the project.

It must not own the decision.

The AI may recommend:

- GO
- CONDITIONAL GO
- SPLIT
- DEFER
- NO-GO

Final execution remains human-owned.

Specialized GPT outputs are second-review evidence only.

They must be accepted, modified, split, deferred, rejected, or converted into NO-GO by the project owner.

---

## 13. Specialized Review Use

Specialized review is recommended when a proposed change affects sensitive domains.

Examples:

| Domain | Review type |
|---|---|
| Clinical safety | Clinical safety review |
| AI/CDS | Clinical AI governance review |
| Privacy/security | Healthcare privacy/security review |
| Validation | Validation governance review |
| Regulatory wording | Medical software compliance review |
| Workflow architecture | Healthcare workflow governance review |
| OpenEMR architecture | EHR architecture review |
| Documentation overlap | Documentation governance audit |
| Platform strategy | Digital health platform review |

Specialized review does not override project boundaries.

Specialized review does not authorize runtime, AI, PHI, clinical use, validation, regulatory, or production claims.

---

## 14. Contributor Training and Competency Recommendation

Before expanding contributor access, runtime planning, validation work, or clinical safety review, the project should define a lightweight contributor competency checklist.

The checklist should confirm that contributors understand:

- documentation-only boundary
- no-PHI rule
- no real patient data rule
- no secrets rule
- no overclaiming rule
- narrow PR rule
- source-of-truth discipline
- clinical safety boundary
- human-supervised AI boundary
- GitHub verification workflow
- revert protocol

This is a governance recommendation only.

It does not create a certification program.

It does not imply regulatory compliance.

---

## 15. Future Automated Tooling Quality Gate

When the project later enters authorized technical implementation or deeper CI/CD governance, it may consider automated checks.

Potential checks include:

- Static Application Security Testing
- secret scanning
- dependency scanning
- Software Composition Analysis
- Markdown linting
- link checking
- PHI or identifier pattern scanning
- SQL migration detection
- runtime file-change detection
- API/FHIR implementation detection
- AI/model/prompt integration detection

### 15.1 Current Boundary

Do not implement these tools unless explicitly authorized in a separate PR.

Do not claim these tools are active unless verified in the repository.

This section is future-only planning guidance.

---

## 16. Synthetic-Only Future Runtime Evidence Rule

If a future gate authorizes any runtime-related evidence activity, it must be limited to:

- non-production environment
- synthetic data only
- no PHI
- no real patient data
- no clinical use
- no patient-care decision-making
- no autonomous AI behavior
- no production readiness claim
- no clinical validation claim
- no regulatory compliance claim
- no cybersecurity certification claim

Any movement beyond this requires:

- formal risk assessment
- formal privacy review
- formal clinical safety review
- formal human approval
- source-of-truth update
- explicit PR audit trail
- updated project-state documentation
- post-change verification

---

## 17. Formal Re-Assessment Trigger List

The AI must re-run risk assessment if any of the following occurs:

- repository state changes
- master changes
- new PR appears
- files change outside intended scope
- branch changes
- conflicts appear
- CI/check status changes
- Documentation Index measurement changes
- risk category changes
- clinical safety wording is introduced
- AI/CDS wording is introduced
- privacy/security wording is introduced
- validation wording is introduced
- regulatory wording is introduced
- runtime wording is introduced
- API/FHIR wording is introduced
- SQL wording is introduced
- OpenEMR core behavior wording is introduced
- any reviewer raises concern
- any evidence becomes stale
- any evidence becomes contradictory
- any intended file path changes
- any PR scope expands

Rule:

No stale GO decisions.
Every GO expires when the evidence or repository state changes.

---

## 18. PR Audit Trail Requirements

Every non-mechanical PR should include a visible audit trail in the PR body.

Required sections:

- Summary
- Execution Risk Assessment
- Scope
- Documentation-Only Boundary
- Safety and Privacy Boundary
- Claims Boundary
- Source-of-Truth / Index Audit Note
- Verification
- Merge Criteria

### 18.1 Execution Risk Assessment Minimum

The PR body must include:

- Risk level: Low / Medium / High / Critical
- External review needed: Yes / No / Already completed
- Decision: GO / CONDITIONAL GO / SPLIT / DEFER / NO-GO
- Reason
- Evidence
- Source-of-truth check
- Claim-control check
- Boundary check
- Smallest safe next action

### 18.2 Optional Scientific Strengthening Addendum Section

For non-mechanical PRs, the following section is recommended:

- Standards alignment note
- Risk-mapping note
- Evidence source
- Source-of-truth note
- Claim-control note
- Privacy/no-PHI note
- Human-supervision note
- Future-stage boundary
- Reassessment trigger

This section must remain concise.

It must not claim compliance, validation, clinical readiness, production readiness, or cybersecurity certification.

---

## 19. Narrow PR Execution Rule

All execution must remain narrow.

The preferred rule is:

One PR.
One purpose.
One narrow change.
No mixed scope.

Do not mix:

- index cleanup with a new framework
- clinical intelligence with Golden Catalog alignment
- roadmap planning with runtime planning
- documentation-only changes with implementation
- validation planning with validation claims
- governance clarification with regulatory compliance claims

Allowed narrow PR types include:

- index-only PR
- single governance document PR
- single boundary clarification PR
- single source-of-truth cleanup PR
- single audit correction PR
- single roadmap clarification PR
- single glossary clarification PR

---

## 20. Revert and Fix-Forward Discipline

Safety-gate breaches must not be treated as routine defects.

Immediate revert is required if a merged change introduces:

- PHI
- real patient data
- secrets
- credentials
- production logs
- database dumps
- runtime code
- AI implementation
- prompt execution
- model integration
- API/FHIR implementation
- SQL/database migration
- OpenEMR core behavior change
- clinical-use authorization
- production-readiness claim
- clinical-validation claim
- regulatory-compliance claim
- cybersecurity-certification claim
- autonomous diagnosis
- autonomous treatment
- autonomous prescribing
- autonomous triage

Fix-forward may be considered only for low-risk documentation defects.

Examples:

- typo
- formatting
- broken internal link
- minor wording correction
- index wording correction
- missing verification note

Fix-forward still requires explicit assessment.

---

## 21. Acceptance Criteria for This Addendum

This addendum is acceptable only if all of the following are true:

- It remains documentation-only.
- It introduces no runtime behavior.
- It introduces no AI implementation.
- It introduces no prompt execution.
- It introduces no model integration.
- It introduces no API/FHIR implementation.
- It introduces no SQL/database migration.
- It introduces no OpenEMR core behavior change.
- It introduces no PHI.
- It introduces no real patient data.
- It makes no clinical-use authorization claim.
- It makes no production-readiness claim.
- It makes no clinical-validation claim.
- It makes no regulatory-compliance claim.
- It makes no cybersecurity-certification claim.
- It strengthens risk classification.
- It strengthens evidence discipline.
- It strengthens traceability.
- It strengthens source-of-truth control.
- It strengthens claim control.
- It preserves human ownership.
- It keeps future standards mapping future-only.

---

## 22. Practical Use Checklist

Before starting any non-mechanical PR, confirm:

- Repository state verified.
- GO decision is current.
- Risk level assigned.
- Evidence identified.
- Source of truth checked.
- Duplicate-document risk checked.
- Claim-control check completed.
- Boundary check completed.
- External review need assessed.
- Smallest safe PR identified.
- PR body includes audit trail.
- Post-merge verification planned.
- Re-measurement planned if applicable.
- Revert protocol understood.

If any item cannot be confirmed, the decision should be:

CONDITIONAL GO, SPLIT, DEFER, or NO-GO

not direct execution.

---

## 23. Final Governance Statement

This addendum strengthens the VFinal governance execution system without changing the current project phase.

OpenEMR IM Core remains a documentation-stage, governance-first, human-supervised, pre-runtime project.

This addendum must not be used to justify implementation, AI integration, prompt execution, model integration, API/FHIR work, SQL/database work, OpenEMR core behavior changes, PHI handling, clinical use, production readiness, clinical validation, regulatory compliance, or cybersecurity certification.

The safest interpretation always prevails.
